Zohydro Maker Assembles Oversight Board Designed to Spot Misuse of Drug

The manufacturer of the recently approved pure hydrocodone drug Zohydro ER (extended release) announced it will assemble an oversight board designed to spot misuse of the drug, the Associated Press reports.

The outside group will consist of seven medical, addiction and law enforcement specialists, according to Stephen Farr, President and Director of Zogenix. The panel will look at data from sources including prescribing statistics, law enforcement records and addiction center reports. “We will be monitoring patients, prescribers, pharmacists, supply chains and abusers, so all the populations that would potentially touch our product,” Farr told the AP.

Full story of Zohydro at drugfree.org

Published by

Will Savage

Quantum Units Continuing Education provides online CEU training's to licensed professional mental health therapists, counselors, social workers and nurses. Our blog provides updates in the field of news and research related to mental health and substance abuse treatment.